Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47365-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diagnostic Value of Riz1 Gene Expression as a Potential Marker for Patients With Hepatocellular Carcinoma.

International Journal of Advanced Research
2016English

Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

MicroRNA-21 as a Diagnostic Marker for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

Pakistan Journal of Medical Sciences
Medicine
2019English

BMI-1 Autoantibody in Serum as a New Potential Biomarker of Nasopharyngeal Carcinoma

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Monocyte Chemoattractant Protein-1 as a Diagnostic Marker for Detection of Hepatocellular Carcinoma in Egypt

Afro-Egyptian Journal of Infectious and Endemic Diseases
2016English

Senescence Marker Protein 30 (SMP30) Serves as a Potential Prognostic Indicator in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy